CLASTEON

This brand name is authorized in Canada, Israel, Italy, Malta, United Kingdom

Active ingredients

The drug CLASTEON contains one active pharmaceutical ingredient (API):

1 Clodronic acid UNII N030400H8J - CLODRONATE DISODIUM

Clodronic acid is a bisphosphonate, (formerly diphosphonates), a group of analogues of pyrophosphate, which have been shown, in vitro, to inhibit the formation and dissolution of calcium phosphate (hydroxyapatite). In vivo, they have been shown to inhibit bone resorption to a greater or lesser extent, depending on the compound, and clodronate is one of the most effective in this respect. Read about Clodronic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CLASTEON Capsule	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M05BA02	Clodronic acid	M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates
Discover more medicines within M05BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02245828
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 115505, 115506, 205406
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8283
Country: IT	Agenzia del Farmaco	Identifier(s): 026372033, 026372058
Country: MT	Medicines Authority	Identifier(s): MA1446/00101